Comparison of two techniques for the evaluation of fetomaternal hemorrhage in RhD-negative women: Gel agglutination and haemoglobin F determination by flow cytometry

Avi Ben-Haroush, Alina Belkin, Judith Chezar, Jerome Orlin, Moshe Hod, Jacob Bar

Research output: Contribution to journalArticlepeer-review

Abstract

Background. In the treatment of RhD-negative women, it is clinically important to adjust the RhD immunoglobulin dose to the volume of the fetal-maternal hemorrhage (FMH). The present study compared a standard flow cytometry technique for FMH quantification to a simple alternative, the gel agglutination test. Methods. Blood samples were collected from 118 RhD negative women after delivery, and were analysed for the amount of FMH by both flow cytometry and the gel agglutination test. Events associated with increased FMH in a previous and current pregnancy, and with neonatal complications, were correlated to the results. Results. A FMH of 0.1 ml or more was detected in all 118 women in the study group by flow cytometry (mean 2.0±1.2 ml), but in only 31 women (35.6% of 87 with RhD positive infant) (mean FMH 0.76±1.48 ml) by the gel agglutination test (p<0.001). On multivariate regression analysis, only gestational age was a weak significant independent positive predictor for FMH (r 2=0.037, p=0.047). Conclusion. The gel agglutination technique, as used in the range of 0.1-10 ml, is not sensitive enough to detect FMH.

Original languageEnglish
Pages (from-to)821-826
Number of pages6
JournalActa Obstetricia et Gynecologica Scandinavica
Volume86
Issue number7
DOIs
StatePublished - 2007

Keywords

  • Fetomaternal hemorrhage
  • Flow cytometry
  • Gel agglutination

Fingerprint

Dive into the research topics of 'Comparison of two techniques for the evaluation of fetomaternal hemorrhage in RhD-negative women: Gel agglutination and haemoglobin F determination by flow cytometry'. Together they form a unique fingerprint.

Cite this